Related Experiment Video
Updated: Jul 1, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Metronomic Chemotherapy in Elderly Patients.
Arianna Bandini1, Pasquale Fabio Calabrò1, Marta Banchi1
1Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 55, 56126, Pisa, Italy.
Metronomic chemotherapy (MCT), a frequent low-dose regimen, offers a feasible and less toxic treatment option for frail elderly cancer patients, supporting its use in geriatric oncology.
Area of Science:
- Geriatric Oncology
- Cancer Therapeutics
- Clinical Trials
Background:
- Cancer incidence increases with age, posing challenges for elderly patients receiving standard high-dose chemotherapy.
- Standard chemotherapy at maximum tolerated dose (MTD) can lead to significant adverse drug reactions in frail elderly individuals.
Purpose of the Study:
- To review scientific literature on metronomic chemotherapy (MCT) in geriatric oncology.
- To evaluate MCT as a feasible treatment for frail elderly cancer patients.
Main Methods:
- Literature review of relevant studies on MCT in geriatric oncology.
- Analysis of clinical trials involving elderly patients with various cancer types.
Main Results:
- Metronomic chemotherapy (MCT) is an emerging schedule in phase II and III clinical trials.
- MCT involves frequent, low-dose administration of chemotherapeutic drugs over a prolonged period.
- This approach aims to overcome the limitations and toxicity associated with MTD regimens.
Conclusions:
- Metronomic chemotherapy (MCT) is presented as a viable and potentially less toxic treatment option for frail elderly patients.
- The reviewed studies support the feasibility of MCT in geriatric oncology settings.
More Related Videos
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Factors Affecting Drug Response: Overview
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules